Eric Wolhford

Eric Wohlford

Eric studied the effects of malaria on B cells in Kenya.  View more...


Leonard B Weiner, MD

Leonard B Weiner, MD
Appointed 10/01/72
5410 Upstate University Hospital - Downtown Campus
750 East Adams Street
Syracuse, NY 13210

315 464-6331

Current Appointments

Hospital Campus

  • Downtown

Clinical Section Affiliations

  • Pediatrics: Infectious Disease

Research Programs and Affiliations

  • Pediatrics


Education & Fellowships

  • Fellowship: Harvard Medical School/Children's Hospital Medical Ctr., Boston, MA, 1970, Pediatric Infectious Disease
  • Residency: Children's Hospital of Philadelphia, 1968
  • Internship: University of Pennsylvania Health System, 1964
  • MD: Tufts University School of Medicine, 1963

Clinical Interests

  • Pediatric infections, immunizations, Pediatric HIV, new antibiotics

Education Interests

  • Training of Pediatric Infectious Disease Fellows

Research Interests

  • Clinical Research focusing on Pediatric and Adolescent Vaccine Trials, antiviral therapeutic trials and epidemiologic studies of pediatric respiratory viral infections.

Clinical Trials

  • A Multicenter, Randomized, Double-Blinded Comparative Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Daptomycin Versus Active Comparator in Pediatric Subjects with Acute Hematogenous Osteomyelitis Due to Gram-Positive Organisms.
    Read more
  • A Phase 2/3Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK) Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co), Administered with an Optimized Background Regimen (BR) in HIV-1 Infected, Treatment-Experienced, Viroligically Suppressed Pediatric Subjects.
    Read more
  • A Phase 2/3Multicenter, Open-Label, Multicohort, Two-Part Study Evaluating the Pharmacokinetics (PK), Safety, and Antiviral Activity of Elvitegravir (EVG) Administered with a Background Regimen (BR) Containing a Ritinavir-Boosted Protease Inhibitor (PI/r) in HIV-1 Infected, Antiretroviral Treatment-Experienced Pediatric Subjects.
    Read more
  • A Phase 3, Multi-center, Open-Label, Randomized, Comparator-Controlled Trial of the Safety and Efficacy of Dalbavancin versus Active Comparator in Pediatric Subjects with Acute Bacterial Skin and Skin Structure Infections
    Read more
  • A Phase I-II, Randomized, Double-Blind, Study to Evaluate the Safety, Tolerability, and Immunogenicity of Different Formulations of V114 in Healthy Adults and Infants
    Read more
  • A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Infants
    Read more
  • A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral naïve HIV-1 infected adolescents and children aged ≥6 to <18 years
    Read more
  • A phase IIIA, randomized, observer-blind, controlled, multinational study to evaluate the safety and immunogenicity of GSK Biologicals' MMR vaccine (209762) (Priorix®) compared to Merck & Co., Inc.￿s MMR vaccine (M-M-R®II or VaxPro), as a first dose, both co-administered with Varivax, Havrix (all subjects) and Prevnar 13 (US subset) in healthy children 12 to 15 months of age.
    Read more
  • A retrospective chart review of disease markers and treatment measures in pediatric Hepatitis A, B and C patients to identify consistent disease parameters for use in clinical management.
    Read more
  • An Open Label, Randomized, Adaptive, Two-Arm, Multicenter Trial to Evaluate Pharmackinetics and Pharmacodynamics of Two Doses of Oseltamivir (Tamilflu) in the Treatment of Influenza in Immunocompromised Children, Less than 13 Years of Age, with Confirmed Influenza Infection.
    Read more
  • Analysis of Existing Newborn Screening Specimens from Children Diagnosed with B Cell Immunodeficiencies or Lymphopenia
    Read more
  • Phase 1, Single-Administration Pharmacokinetic and Safety Study of Oral and IV Tedizolid Phosphate in Hospitalized Subjects 2 to <12 Years Old
    Read more
  • Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
    Read more

Specialties & Certification

  • Pediatrics
  • Pediatric Infectious Diseases

Diseases & Conditions Treated

  • Antibiotic-Associated Diarrhea
  • Antibiotic-Resistant Infections
  • Bacterial Meningitis in Children
  • Fever
  • Giardiasis
  • HIV Infection and AIDS
  • Herpes Encephalitis
  • Immune Abnormalities
  • Infections of Bones and Joints
  • Infectious Mononucleosis
  • Infective Endocarditis
  • Pneumonia
  • Shingles
  • Tuberculosis (TB)
  • Viral Infections in Children
  • Viral Meningitis in Children
  • Yeast Infection or Candidiasis


  • Adults and Children


  • American Academy of Pediatrics
  • Alpha Omega Alpha Honour Society
  • Infectious Diseases Society of America (IDSA)
  • Onondaga County Pediatric Society

Current Hospital Privileges

  • Upstate University Hospital
  • Crouse Hospital


Blatter M, Weiner L, Kennedy D, Bologa M:  Safety of Tetanus-Diphtheria-Acellular Pertussis (Tdap) Vaccine in Adults.  17th World Conference of Family Doctors, WONCA 2004.

Polak M, Weiner L, Cragin L, McLaurin K, Sorenson S, Groothuis J, Mahadevia P.  Cost-effectiveness of RSV Prophylaxis with Palivizumab after Valuing a Reduction in Recurrent Wheezing Among Preterm Infants 32-35 Weeks Gestation, American Academy of Pediatrics Conference, San FranciscoCA, 2007.

Suryadevara M, Moro MR, Rosenbaum P, Kika D, Ridell S, Shaw J.  Invasive community-acquired methicililn-resistant Staphylococcus aureus infections in children in upstate New York.  Pediatric Academic Societies, Honolulu HI, May 2008.

Moro MR, Contello K, Holz W, Weiner LB, Shaw J.  Subcutaneous (SCIG) veruss Intravenous (IVIG Immunoglobulin Replacement Therapy in a Pediatric Population with Primary Immunodeficiencies (PID).  Pediatric Academic Societies, Baltimore MD, May 2009.


Frankowski, BL, Weiner, LB, the Committee on School Health and the Committee on Infectious Diseases, AmericanAcademy of Pediatrics:  Head Lice.  Pediatrics, 2002;110:638-643.

Havens, PL and the Committee on Pediatric AIDS, AmericanAcademy of Pediatrics:  Postexposure Prophylaxis in Children and Adolescents for Nonoccupational Exposure to Human Immunodeficiency Virus.  Pediatrics, 2003;111(6):1475-1489.

Samkari A, Kiska DL, Riddell SW, Wilson K, Weiner LB, and Domachowske JB.  Dipylidium Caninum Mimicking Recurrent Enterobius Vermicularis (Pinworm) Infection.  Clin Pediatr, 2007.



Clinical Profile Shortcut:
Faculty Profile Shortcut: